Leidos Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Leidos Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-07-04 | 2025-04-04 | 2025-01-03 | 2024-09-27 | 2024-06-28 | 2024-03-29 | 2023-12-29 | 2023-09-29 | 2023-06-30 | 2023-03-31 | 2022-12-30 | 2022-09-30 | 2022-07-01 | 2022-04-01 | 2021-12-31 | 2021-10-01 | 2021-07-02 | 2021-04-02 | 2021-01-01 | 2020-10-02 | 2020-07-03 | 2020-04-03 | 2020-01-03 | 2019-09-27 | 2019-06-28 | 2019-03-29 | 2018-12-28 | 2018-09-28 | 2018-06-29 | 2018-03-30 | 2017-12-29 | 2017-09-29 | 2017-06-30 | 2017-03-31 | 2016-12-30 | 2016-09-30 | 2016-07-01 | 2016-04-01 | 2015-10-02 | 2015-07-03 | 2015-04-03 | 2015-01-30 | 2014-10-31 | 2014-08-01 | 2014-05-02 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operations: | |||||||||||||||||||||||||||||||||||||||||||||
net income | 393,000,000 | 365,000,000 | 282,000,000 | 362,000,000 | 324,000,000 | 283,000,000 | 230,000,000 | -396,000,000 | 210,000,000 | 164,000,000 | 180,000,000 | 164,000,000 | 172,000,000 | 177,000,000 | 176,000,000 | 208,000,000 | 170,000,000 | 205,000,000 | 197,000,000 | 163,000,000 | 154,000,000 | 115,000,000 | 181,000,000 | 162,000,000 | 138,000,000 | 189,000,000 | 188,000,000 | 147,000,000 | 145,000,000 | 102,000,000 | 113,000,000 | 79,000,000 | 98,000,000 | 74,000,000 | 60,000,000 | 92,000,000 | 45,000,000 | 49,000,000 | 45,000,000 | 41,000,000 | 41,000,000 | 44,000,000 | 34,000,000 | -438,000,000 | 37,000,000 |
adjustments to reconcile net income to net cash from operations: | |||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 72,000,000 | 69,000,000 | 79,000,000 | 71,000,000 | 71,000,000 | 69,000,000 | 83,000,000 | 82,000,000 | 84,000,000 | 82,000,000 | 84,000,000 | 81,000,000 | 83,000,000 | 85,000,000 | 81,000,000 | 87,000,000 | 80,000,000 | 77,000,000 | 68,000,000 | 82,000,000 | 71,000,000 | 61,000,000 | 60,000,000 | 59,000,000 | 57,000,000 | 58,000,000 | 64,000,000 | 64,000,000 | 66,000,000 | 63,000,000 | 82,000,000 | 92,000,000 | 80,000,000 | 82,000,000 | 68,000,000 | 37,000,000 | 9,000,000 | 8,000,000 | 11,000,000 | 12,000,000 | 12,000,000 | 12,000,000 | 16,000,000 | 15,000,000 | 19,000,000 |
stock-based compensation | 25,000,000 | 21,000,000 | 26,000,000 | 19,000,000 | 20,000,000 | 20,000,000 | 20,000,000 | 20,000,000 | 19,000,000 | 18,000,000 | 20,000,000 | 18,000,000 | 19,000,000 | 16,000,000 | 18,000,000 | 17,000,000 | 17,000,000 | 15,000,000 | 17,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | 14,000,000 | 13,000,000 | 13,000,000 | 12,000,000 | 11,000,000 | 10,000,000 | 12,000,000 | 11,000,000 | 11,000,000 | 12,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 9,000,000 | 8,000,000 | 8,000,000 | 9,000,000 | 8,000,000 | 6,000,000 | 9,000,000 | 10,000,000 | 12,000,000 | 11,000,000 |
deferred income taxes | 224,000,000 | -24,000,000 | -2,000,000 | -29,000,000 | -42,000,000 | -25,000,000 | 83,000,000 | -104,000,000 | -45,000,000 | -43,000,000 | 10,000,000 | -85,000,000 | -75,000,000 | -61,000,000 | -30,000,000 | 1,000,000 | -2,000,000 | -1,000,000 | -3,000,000 | 2,000,000 | -15,000,000 | 0 | 23,000,000 | 10,000,000 | |||||||||||||||||||||
other | -1,000,000 | 39,000,000 | 3,000,000 | 8,000,000 | -6,000,000 | 3,000,000 | 19,000,000 | 1,000,000 | 5,000,000 | 5,000,000 | 14,000,000 | 3,000,000 | 4,000,000 | 10,000,000 | 0 | -3,000,000 | -8,000,000 | -3,000,000 | -7,000,000 | -17,000,000 | 28,000,000 | -1,000,000 | 0 | 0 | 3,000,000 | 3,000,000 | 7,000,000 | -14,000,000 | 8,000,000 | 13,000,000 | 2,000,000 | 2,000,000 | -1,000,000 | -2,000,000 | 8,000,000 | -4,000,000 | -1,000,000 | -1,000,000 | 5,000,000 | -1,000,000 | |||||
change in assets and liabilities, net of effects of acquisition: | |||||||||||||||||||||||||||||||||||||||||||||
receivables | 10,000,000 | -246,000,000 | 40,000,000 | -75,000,000 | 96,000,000 | -281,000,000 | 44,000,000 | 14,000,000 | 43,000,000 | -166,000,000 | -36,000,000 | 100,000,000 | -6,000,000 | -232,000,000 | 98,000,000 | -14,000,000 | -79,000,000 | -10,000,000 | -267,000,000 | -86,000,000 | 137,000,000 | 89,000,000 | 48,000,000 | 36,000,000 | 53,000,000 | -21,000,000 | -60,000,000 | -34,000,000 | 120,000,000 | -84,000,000 | -36,000,000 | 24,000,000 | 11,000,000 | -190,000,000 | -17,000,000 | 216,000,000 | -28,000,000 | -48,000,000 | 82,000,000 | 46,000,000 | 17,000,000 | 133,000,000 | 85,000,000 | -7,000,000 | -49,000,000 |
other current assets and other long-term assets | -7,000,000 | -27,000,000 | -6,000,000 | 95,000,000 | 42,000,000 | -35,000,000 | -1,000,000 | 92,000,000 | 58,000,000 | -9,000,000 | 28,000,000 | 59,000,000 | 101,000,000 | -28,000,000 | -18,000,000 | 70,000,000 | 86,000,000 | 5,000,000 | 55,000,000 | 34,000,000 | 58,000,000 | -43,000,000 | |||||||||||||||||||||||
accounts payable and accrued liabilities and other long-term liabilities | -188,000,000 | -72,000,000 | -11,000,000 | 25,000,000 | -73,000,000 | -101,000,000 | 9,000,000 | 220,000,000 | -101,000,000 | -97,000,000 | -92,000,000 | 214,000,000 | -211,000,000 | -60,000,000 | -40,000,000 | 175,000,000 | -199,000,000 | -148,000,000 | -60,000,000 | 255,000,000 | -69,000,000 | 25,000,000 | |||||||||||||||||||||||
accrued payroll and employee benefits | 155,000,000 | -148,000,000 | -87,000,000 | 198,000,000 | -38,000,000 | 48,000,000 | -110,000,000 | 137,000,000 | -45,000,000 | 13,000,000 | -119,000,000 | 116,000,000 | -23,000,000 | 124,000,000 | -115,000,000 | 37,000,000 | -4,000,000 | 50,000,000 | -86,000,000 | 177,000,000 | 2,000,000 | 68,000,000 | -12,000,000 | -108,000,000 | 59,000,000 | -36,000,000 | 72,000,000 | -107,000,000 | 52,000,000 | -37,000,000 | 79,000,000 | -86,000,000 | 28,000,000 | -4,000,000 | 53,000,000 | -51,000,000 | -6,000,000 | 39,000,000 | -59,000,000 | -24,000,000 | -9,000,000 | 44,000,000 | -32,000,000 | ||
income taxes receivable/payable | -199,000,000 | 121,000,000 | -66,000,000 | -19,000,000 | -34,000,000 | 91,000,000 | -57,000,000 | 24,000,000 | -60,000,000 | -65,000,000 | -12,000,000 | 64,000,000 | -23,000,000 | 68,000,000 | 35,000,000 | -19,000,000 | -54,000,000 | 53,000,000 | 21,000,000 | -51,000,000 | 32,000,000 | 12,000,000 | 83,000,000 | -13,000,000 | -98,000,000 | -65,000,000 | -33,000,000 | -3,000,000 | 14,000,000 | ||||||||||||||||
net cash from operating activities | 486,000,000 | 58,000,000 | 299,000,000 | 656,000,000 | 374,000,000 | 63,000,000 | 304,000,000 | 795,000,000 | 164,000,000 | -98,000,000 | 105,000,000 | 748,000,000 | 40,000,000 | 93,000,000 | 210,000,000 | 565,000,000 | 17,000,000 | 239,000,000 | -52,000,000 | 592,000,000 | 422,000,000 | 372,000,000 | 169,000,000 | 349,000,000 | 186,000,000 | 288,000,000 | 371,000,000 | 271,000,000 | 22,000,000 | ||||||||||||||||
capex | -29,000,000 | -22,000,000 | -86,000,000 | -23,000,000 | -23,000,000 | -17,000,000 | -78,000,000 | -50,000,000 | -40,000,000 | -39,000,000 | -53,000,000 | -27,000,000 | -21,000,000 | -28,000,000 | -33,000,000 | -24,000,000 | -21,000,000 | -26,000,000 | -63,000,000 | -30,000,000 | -46,000,000 | -44,000,000 | -54,000,000 | -21,000,000 | -16,000,000 | -30,000,000 | -25,000,000 | -13,000,000 | -15,000,000 | ||||||||||||||||
free cash flows | 457,000,000 | 36,000,000 | 213,000,000 | 633,000,000 | 351,000,000 | 46,000,000 | 226,000,000 | 745,000,000 | 124,000,000 | -137,000,000 | 52,000,000 | 721,000,000 | 19,000,000 | 65,000,000 | 177,000,000 | 541,000,000 | -4,000,000 | 213,000,000 | -115,000,000 | 562,000,000 | 376,000,000 | 328,000,000 | 115,000,000 | 328,000,000 | 170,000,000 | 258,000,000 | 346,000,000 | 258,000,000 | 7,000,000 | ||||||||||||||||
cash flows from investing activities: | |||||||||||||||||||||||||||||||||||||||||||||
acquisition of a business, net of cash acquired | -2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
payments for property, equipment and software | -29,000,000 | -22,000,000 | -86,000,000 | -23,000,000 | -23,000,000 | -17,000,000 | -78,000,000 | -50,000,000 | -40,000,000 | -39,000,000 | -53,000,000 | -27,000,000 | -21,000,000 | -28,000,000 | -33,000,000 | -24,000,000 | -21,000,000 | -26,000,000 | -63,000,000 | -30,000,000 | -46,000,000 | -44,000,000 | -54,000,000 | -21,000,000 | -16,000,000 | -30,000,000 | |||||||||||||||||||
net proceeds from sale of assets | 0 | 0 | 0 | 0 | 2,000,000 | 0 | 0 | 0 | 96,000,000 | 1,000,000 | 0 | 0 | 0 | 0 | 3,000,000 | ||||||||||||||||||||||||||||||
net cash from investing activities | -314,000,000 | -22,000,000 | -86,000,000 | -23,000,000 | -21,000,000 | -12,000,000 | -76,000,000 | -52,000,000 | -44,000,000 | -39,000,000 | -258,000,000 | -26,000,000 | -8,000,000 | -21,000,000 | -37,000,000 | -53,000,000 | -396,000,000 | -244,000,000 | -101,000,000 | -15,000,000 | -1,014,000,000 | -1,685,000,000 | -54,000,000 | -102,000,000 | -16,000,000 | 237,000,000 | 15,000,000 | -13,000,000 | -96,000,000 | ||||||||||||||||
cash flows from financing activities: | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from debt issuance | 0 | 997,000,000 | 0 | 0 | 0 | 1,743,000,000 | 0 | 0 | 0 | 0 | 1,000,000,000 | 0 | 3,050,000,000 | 3,175,000,000 | 0 | ||||||||||||||||||||||||||||||
repayments of borrowings | -30,000,000 | -529,000,000 | -4,000,000 | -5,000,000 | -5,000,000 | -4,000,000 | -4,000,000 | -5,000,000 | -325,000,000 | -1,711,000,000 | -86,000,000 | -25,000,000 | |||||||||||||||||||||||||||||||||
payments for debt issuance costs | 0 | -7,000,000 | 0 | 0 | -7,000,000 | 0 | -27,000,000 | -12,000,000 | 0 | ||||||||||||||||||||||||||||||||||||
dividend payments | -52,000,000 | -53,000,000 | -53,000,000 | -51,000,000 | -51,000,000 | -53,000,000 | -51,000,000 | -50,000,000 | -50,000,000 | -50,000,000 | -50,000,000 | -49,000,000 | -49,000,000 | -51,000,000 | -50,000,000 | -51,000,000 | -48,000,000 | -50,000,000 | -48,000,000 | -49,000,000 | -48,000,000 | -51,000,000 | -97,000,000 | 0 | -47,000,000 | -54,000,000 | -47,000,000 | -48,000,000 | -51,000,000 | -52,000,000 | -48,000,000 | -48,000,000 | -52,000,000 | -50,000,000 | -48,000,000 | -48,000,000 | -23,000,000 | -23,000,000 | -24,000,000 | -23,000,000 | -24,000,000 | -24,000,000 | -24,000,000 | ||
repurchases of stock and other | -9,000,000 | -528,000,000 | -406,000,000 | -203,000,000 | -114,000,000 | -183,000,000 | -202,000,000 | -1,000,000 | 0 | -43,000,000 | -10,000,000 | -4,000,000 | -2,000,000 | -526,000,000 | -4,000,000 | -140,000,000 | -3,000,000 | -123,000,000 | -70,000,000 | -1,000,000 | -2,000,000 | -32,000,000 | -28,000,000 | -203,000,000 | -5,000,000 | -222,000,000 | -256,000,000 | -66,000,000 | -94,000,000 | -22,000,000 | -5,000,000 | -1,000,000 | -19,000,000 | -6,000,000 | -4,000,000 | ||||||||||
proceeds from issuances of stock | 16,000,000 | 15,000,000 | 27,000,000 | 2,000,000 | 13,000,000 | 13,000,000 | 13,000,000 | 12,000,000 | 13,000,000 | 12,000,000 | 13,000,000 | 13,000,000 | 10,000,000 | 12,000,000 | 11,000,000 | 10,000,000 | 10,000,000 | 13,000,000 | 9,000,000 | 10,000,000 | 8,000,000 | 8,000,000 | 11,000,000 | 1,000,000 | 5,000,000 | 10,000,000 | 1,000,000 | 5,000,000 | 4,000,000 | 4,000,000 | 3,000,000 | 3,000,000 | 6,000,000 | 1,000,000 | 0 | ||||||||||
net capital distributions to non-controlling interests | -2,000,000 | -5,000,000 | -3,000,000 | 0 | -2,000,000 | -1,000,000 | -5,000,000 | -2,000,000 | -1,000,000 | ||||||||||||||||||||||||||||||||||||
net cash from financing activities | -83,000,000 | -110,000,000 | -440,000,000 | -257,000,000 | -159,000,000 | -228,000,000 | -245,000,000 | -249,000,000 | -164,000,000 | -57,000,000 | -135,000,000 | -217,000,000 | 6,000,000 | -519,000,000 | -69,000,000 | -209,000,000 | 313,000,000 | -148,000,000 | 98,000,000 | -517,000,000 | 709,000,000 | 1,161,000,000 | -144,000,000 | -204,000,000 | -64,000,000 | -297,000,000 | -134,000,000 | -192,000,000 | -91,000,000 | ||||||||||||||||
effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | 7,000,000 | 7,000,000 | 9,000,000 | 0 | -4,000,000 | 1,000,000 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash | -242,000,000 | 385,000,000 | -11,000,000 | -288,000,000 | 104,000,000 | -55,000,000 | 60,000,000 | 117,000,000 | -152,000,000 | -29,000,000 | 43,000,000 | 106,000,000 | 228,000,000 | -206,000,000 | |||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at beginning of period | 0 | 991,000,000 | 0 | 0 | 928,000,000 | 0 | 0 | 683,000,000 | 0 | 0 | 875,000,000 | 0 | 0 | 687,000,000 | 0 | 0 | 717,000,000 | 0 | 0 | 369,000,000 | 0 | 0 | 422,000,000 | ||||||||||||||||||||||
cash, cash equivalents and restricted cash at end of period | 96,000,000 | 924,000,000 | 385,000,000 | 194,000,000 | 747,000,000 | 491,000,000 | -43,000,000 | 491,000,000 | 505,000,000 | 38,000,000 | 428,000,000 | 303,000,000 | -66,000,000 | 534,000,000 | 60,000,000 | 117,000,000 | 565,000,000 | 43,000,000 | 106,000,000 | 597,000,000 | 252,000,000 | 66,000,000 | 257,000,000 | ||||||||||||||||||||||
less: restricted cash at end of period | 8,000,000 | 82,000,000 | 23,000,000 | 4,000,000 | 114,000,000 | 70,000,000 | 7,000,000 | 112,000,000 | 37,000,000 | -4,000,000 | 131,000,000 | 54,000,000 | -27,000,000 | 157,000,000 | |||||||||||||||||||||||||||||||
cash and cash equivalents at end of period | 88,000,000 | 842,000,000 | 362,000,000 | 190,000,000 | 633,000,000 | 421,000,000 | -50,000,000 | 379,000,000 | 468,000,000 | 42,000,000 | 297,000,000 | 249,000,000 | -39,000,000 | 377,000,000 | 56,000,000 | 206,000,000 | -221,000,000 | 61,000,000 | 609,000,000 | 270,000,000 | -12,000,000 | 377,000,000 | 60,000,000 | 175,000,000 | 183,000,000 | ||||||||||||||||||||
6 | |||||||||||||||||||||||||||||||||||||||||||||
change in assets and liabilities | |||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -67,000,000 | -181,000,000 | -43,000,000 | -192,000,000 | 38,000,000 | -447,000,000 | -66,000,000 | -153,000,000 | 66,000,000 | -165,000,000 | |||||||||||||||||||||||||||||||||||
leidos holdings, inc. | 5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
goodwill impairment charges | -3,000,000 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||
asset impairment charges | 5,000,000 | 3,000,000 | 37,000,000 | 1,000,000 | 1,000,000 | 0 | 0 | 0 | 0 | 7,000,000 | 4,000,000 | 29,000,000 | 40,000,000 | ||||||||||||||||||||||||||||||||
change in assets and liabilities, net of effects of acquisitions and dispositions: | |||||||||||||||||||||||||||||||||||||||||||||
acquisitions of businesses, net of cash acquired | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from disposition of businesses | -5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
payments for debt issuance and modification costs | -2,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||
effect of foreign exchange rate changes on cash and cash equivalents | |||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at beginning of year | |||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at end of year | |||||||||||||||||||||||||||||||||||||||||||||
less: restricted cash at end of year | |||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at end of year | |||||||||||||||||||||||||||||||||||||||||||||
66 | |||||||||||||||||||||||||||||||||||||||||||||
change in assets and liabilities, net of effects of acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||
supplementary cash flow information: | |||||||||||||||||||||||||||||||||||||||||||||
cash paid for income taxes, net of refunds | 113,000,000 | 161,000,000 | 2,000,000 | 110,000,000 | 46,000,000 | 144,000,000 | 135,000,000 | 51,000,000 | 39,000,000 | 119,000,000 | 8,000,000 | 42,000,000 | 69,000,000 | 102,000,000 | 8,000,000 | ||||||||||||||||||||||||||||||
cash paid for interest | 60,000,000 | 46,000,000 | 61,000,000 | 47,000,000 | 64,000,000 | 51,000,000 | 45,000,000 | 59,000,000 | 29,000,000 | 69,000,000 | 38,000,000 | 54,000,000 | 26,000,000 | 67,000,000 | 35,000,000 | ||||||||||||||||||||||||||||||
non-cash investing activity: | |||||||||||||||||||||||||||||||||||||||||||||
property, plant and equipment additions | 15,000,000 | 22,000,000 | 35,000,000 | 0 | 1,000,000 | 0 | 1,000,000 | 0 | 2,000,000 | 3,000,000 | 2,000,000 | 3,000,000 | |||||||||||||||||||||||||||||||||
non-cash financing activity: | |||||||||||||||||||||||||||||||||||||||||||||
finance lease obligations | 0 | 0 | 0 | 65,000,000 | 0 | 0 | 1,000,000 | 5,000,000 | 0 | 45,000,000 | |||||||||||||||||||||||||||||||||||
net proceeds from commercial paper | 75,000,000 | 75,000,000 | |||||||||||||||||||||||||||||||||||||||||||
change in assets and liabilities: | |||||||||||||||||||||||||||||||||||||||||||||
net capital (distributions to) contributions from non-controlling interests | -2,000,000 | -2,000,000 | |||||||||||||||||||||||||||||||||||||||||||
divestiture of a business | 0 | 6,000,000 | 9,000,000 | ||||||||||||||||||||||||||||||||||||||||||
favorable impact | 22,000,000 | -3,000,000 | -2,000,000 | 41,000,000 | 10,000,000 | 6,000,000 | 31,000,000 | ||||||||||||||||||||||||||||||||||||||
unfavorable impact | -16,000,000 | -9,000,000 | 6,000,000 | -26,000,000 | 5,000,000 | -10,000,000 | -19,000,000 | ||||||||||||||||||||||||||||||||||||||
net impact to income before income taxes | 6,000,000 | -12,000,000 | 4,000,000 | 15,000,000 | 15,000,000 | -4,000,000 | 12,000,000 | ||||||||||||||||||||||||||||||||||||||
impact on diluted eps attributable to leidos common stockholders | 30,000 | -70,000 | 20,000 | 80,000 | 80,000 | -20,000 | 60,000 | ||||||||||||||||||||||||||||||||||||||
loss on debt extinguishment | 5,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||
acquisition of businesses, net of cash acquired | 0 | 0 | -2,000,000 | -29,000,000 | -375,000,000 | -218,000,000 | 0 | ||||||||||||||||||||||||||||||||||||||
payments of long-term debt | -27,000,000 | -26,000,000 | -27,000,000 | -27,000,000 | -26,000,000 | -776,000,000 | -477,000,000 | -2,276,000,000 | -1,927,000,000 | -30,000,000 | -2,000,000 | -17,000,000 | -31,000,000 | 0 | -15,000,000 | -27,000,000 | -17,000,000 | -15,000,000 | -125,000,000 | -47,000,000 | -22,000,000 | -175,000,000 | |||||||||||||||||||||||
net capital (distribution to) contributions from non-controlling interests | -2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
gain on sale of businesses | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
bad debt expense and recoveries | |||||||||||||||||||||||||||||||||||||||||||||
collections on promissory notes | |||||||||||||||||||||||||||||||||||||||||||||
capital distributions to non-controlling interests | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
capital contributions from non-controlling interests | 0 | -1,000,000 | 4,000,000 | 38,000,000 | |||||||||||||||||||||||||||||||||||||||||
bad debt expense | 2,000,000 | -7,000,000 | -1,000,000 | -1,000,000 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||
payment of tax indemnification liability | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from real estate financing transaction | |||||||||||||||||||||||||||||||||||||||||||||
gain on sale of business | 1,000,000 | -88,000,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from disposition of business | 0 | 171,000,000 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||
acquisition of business, net of cash acquired | -1,642,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
amortization of equity method investments | |||||||||||||||||||||||||||||||||||||||||||||
non-cash interest income | |||||||||||||||||||||||||||||||||||||||||||||
promissory note impairment | |||||||||||||||||||||||||||||||||||||||||||||
other current assets | 5,000,000 | -33,000,000 | 39,000,000 | -55,000,000 | |||||||||||||||||||||||||||||||||||||||||
accounts payable and accrued liabilities | -137,000,000 | 189,000,000 | -176,000,000 | 240,000,000 | -107,000,000 | 128,000,000 | -127,000,000 | 60,000,000 | 147,000,000 | 128,000,000 | -86,000,000 | -37,000,000 | -61,000,000 | 29,000,000 | -11,000,000 | 18,000,000 | 57,000,000 | -16,000,000 | 30,000,000 | -32,000,000 | 24,000,000 | -60,000,000 | 25,000,000 | ||||||||||||||||||||||
other long-term assets | |||||||||||||||||||||||||||||||||||||||||||||
other long-term liabilities | 2,000,000 | -9,000,000 | -4,000,000 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||
acquisitions of businesses | 0 | 0 | 0 | 0 | -81,000,000 | ||||||||||||||||||||||||||||||||||||||||
deferred income taxes and income taxes receivable/payable | 1,000,000 | -46,000,000 | 54,000,000 | -42,000,000 | 13,000,000 | -38,000,000 | 28,000,000 | -101,000,000 | -6,000,000 | -75,000,000 | 31,000,000 | 55,000,000 | -26,000,000 | -6,000,000 | 13,000,000 | ||||||||||||||||||||||||||||||
other long-term assets/liabilities | -80,000,000 | -1,000,000 | 4,000,000 | 39,000,000 | 63,000,000 | -12,000,000 | -2,000,000 | -118,000,000 | 55,000,000 | 6,000,000 | 20,000,000 | -10,000,000 | -11,000,000 | 3,000,000 | -2,000,000 | -2,000,000 | |||||||||||||||||||||||||||||
collections on promissory note | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
payments for non-controlling interest acquired | 0 | ||||||||||||||||||||||||||||||||||||||||||||
change in assets and liabilities, net of effects of dispositions: | |||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from continuing operations: | |||||||||||||||||||||||||||||||||||||||||||||
non-cash interest expense | |||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities of continuing operations | 164,000,000 | 273,000,000 | |||||||||||||||||||||||||||||||||||||||||||
payments for property, plant and equipment | -20,000,000 | -25,000,000 | -13,000,000 | -15,000,000 | -39,000,000 | -19,000,000 | -16,000,000 | -7,000,000 | -9,000,000 | ||||||||||||||||||||||||||||||||||||
net cash from investing activities of continuing operations | -38,000,000 | -19,000,000 | |||||||||||||||||||||||||||||||||||||||||||
special cash dividend payment | 0 | ||||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities of continuing operations | -65,000,000 | -175,000,000 | |||||||||||||||||||||||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash from continuing operations | |||||||||||||||||||||||||||||||||||||||||||||
cash flows from discontinued operations: | |||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities of discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||
bad debt expense and other | 7,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
inventory, prepaid expenses and other current assets | 9,000,000 | 30,000,000 | -63,000,000 | -30,000,000 | -81,000,000 | 29,000,000 | 6,000,000 | 23,000,000 | -117,000,000 | 4,000,000 | -11,000,000 | -12,000,000 | 19,000,000 | -29,000,000 | -14,000,000 | -7,000,000 | 46,000,000 | -37,000,000 | |||||||||||||||||||||||||||
proceeds from sale of assets | 4,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||
gain on a real estate sale | |||||||||||||||||||||||||||||||||||||||||||||
payments on accrued purchase price related to prior acquisition | 0 | ||||||||||||||||||||||||||||||||||||||||||||
payments on real estate financing transaction | |||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities of discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||
acquisition of business | |||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash from continuing operations | |||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents from continuing operations | |||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | |||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of period | 0 | 376,000,000 | 0 | 0 | 656,000,000 | 0 | 0 | 459,000,000 | 0 | 0 | 430,000,000 | ||||||||||||||||||||||||||||||||||
total cash flows used in operating activities of continuing operations | -88,000,000 | -18,000,000 | -42,000,000 | -8,000,000 | |||||||||||||||||||||||||||||||||||||||||
proceeds from collections on promissory note | 2,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||
total cash flows used in investing activities of continuing operations | -5,000,000 | -1,000,000 | -173,000,000 | -2,000,000 | |||||||||||||||||||||||||||||||||||||||||
total cash flows used in financing activities of continuing operations | -77,000,000 | -227,000,000 | -463,000,000 | -34,000,000 | -27,000,000 | -182,000,000 | 10,000,000 | -57,000,000 | -96,000,000 | -126,000,000 | -23,000,000 | -233,000,000 | |||||||||||||||||||||||||||||||||
decrease in cash and cash equivalents from continuing operations | -170,000,000 | -46,000,000 | -12,000,000 | -101,000,000 | 3,000,000 | 49,000,000 | 168,000,000 | -251,000,000 | |||||||||||||||||||||||||||||||||||||
cash from investing activities of discontinued operations | 0 | 0 | 0 | -1,000,000 | 0 | 0 | 6,000,000 | 2,000,000 | 19,000,000 | ||||||||||||||||||||||||||||||||||||
decrease in cash and cash equivalents from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||
total decrease in cash and cash equivalents | -170,000,000 | -47,000,000 | -12,000,000 | -82,000,000 | 175,000,000 | -247,000,000 | |||||||||||||||||||||||||||||||||||||||
total cash flows from operating activities of continuing operations | 162,000,000 | 226,000,000 | 269,000,000 | 102,000,000 | 179,000,000 | ||||||||||||||||||||||||||||||||||||||||
proceeds from u.s. treasury cash grant | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||
total cash flows from investing activities of continuing operations | -8,000,000 | 16,000,000 | -3,000,000 | -4,000,000 | 68,000,000 | -10,000,000 | |||||||||||||||||||||||||||||||||||||||
increase in cash and cash equivalents from continuing operations | -73,000,000 | -221,000,000 | |||||||||||||||||||||||||||||||||||||||||||
cash from operating activities of discontinued operations | 0 | 0 | 13,000,000 | 20,000,000 | -8,000,000 | -1,000,000 | 4,000,000 | ||||||||||||||||||||||||||||||||||||||
increase in cash and cash equivalents from discontinued operations | 0 | 0 | 0 | -1,000,000 | 0 | 0 | 19,000,000 | 22,000,000 | 11,000,000 | 7,000,000 | 4,000,000 | ||||||||||||||||||||||||||||||||||
total increase in cash and cash equivalents | -73,000,000 | -221,000,000 | 25,000,000 | ||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of year | |||||||||||||||||||||||||||||||||||||||||||||
expenditures for property, plant and equipment | -3,000,000 | -4,000,000 | -7,000,000 | -5,000,000 | -3,000,000 | -3,000,000 | -4,000,000 | -12,000,000 | -10,000,000 | ||||||||||||||||||||||||||||||||||||
payments of notes payable and long-term debt | -1,000,000 | -1,000,000 | -2,000,000 | -18,000,000 | -29,000,000 | -103,000,000 | |||||||||||||||||||||||||||||||||||||||
sales of stock and exercises of stock options | 4,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||
repurchases of stock and stock received for tax withholdings | -10,000,000 | -9,000,000 | -6,000,000 | ||||||||||||||||||||||||||||||||||||||||||
(income) income from discontinued operations | 0 | 0 | -18,000,000 | ||||||||||||||||||||||||||||||||||||||||||
proceeds from disposition of business, net of cash sold of 2 million | |||||||||||||||||||||||||||||||||||||||||||||
proceeds on obligations of leidos holdings, inc. | |||||||||||||||||||||||||||||||||||||||||||||
payments on obligations of leidos holdings, inc. | |||||||||||||||||||||||||||||||||||||||||||||
other long-term assets / liabilities | -6,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
cash flows from operating activities of continuing operations: | |||||||||||||||||||||||||||||||||||||||||||||
restructuring charges | 2,000,000 | 0 | 2,000,000 | -1,000,000 | |||||||||||||||||||||||||||||||||||||||||
other assets | 4,000,000 | -1,000,000 | 2,000,000 | -3,000,000 | |||||||||||||||||||||||||||||||||||||||||
cash flows from investing activities of continuing operations: | |||||||||||||||||||||||||||||||||||||||||||||
acquisitions of businesses, net of cash acquired of 9 million in fiscal 2013 | |||||||||||||||||||||||||||||||||||||||||||||
net proceeds for purchase price adjustments related to prior year acquisitions | |||||||||||||||||||||||||||||||||||||||||||||
net proceeds of cost method investments | |||||||||||||||||||||||||||||||||||||||||||||
dividend received from the separation of new saic | |||||||||||||||||||||||||||||||||||||||||||||
contribution paid related to the separation of new saic | |||||||||||||||||||||||||||||||||||||||||||||
cash flows from financing activities of continuing operations: | |||||||||||||||||||||||||||||||||||||||||||||
payments on notes payable and long-term debt | |||||||||||||||||||||||||||||||||||||||||||||
payments for deferred financing costs | |||||||||||||||||||||||||||||||||||||||||||||
payment from new saic for deferred financing costs | |||||||||||||||||||||||||||||||||||||||||||||
distribution of debt to new saic | |||||||||||||||||||||||||||||||||||||||||||||
repurchases of stock | -2,000,000 | -1,000,000 | 0 | -212,000,000 | |||||||||||||||||||||||||||||||||||||||||
cash from financing activities of discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||
loss (income) from discontinued operations | 4,000,000 | -2,000,000 | 9,000,000 | ||||||||||||||||||||||||||||||||||||||||||
intangible asset impairment charges | 17,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
payments of deferred financing costs | |||||||||||||||||||||||||||||||||||||||||||||
payments from new saic for deferred financing costs | |||||||||||||||||||||||||||||||||||||||||||||
net gain on sales and disposals of assets | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
intangible asset impairment losses | |||||||||||||||||||||||||||||||||||||||||||||
inventory write-down | |||||||||||||||||||||||||||||||||||||||||||||
increase in cash and cash equivalents, net of effects of acquisitions and dispositions, resulting from changes in: | |||||||||||||||||||||||||||||||||||||||||||||
net proceeds (purchases) of cost method investments | |||||||||||||||||||||||||||||||||||||||||||||
excess tax benefits from stock-based compensation | |||||||||||||||||||||||||||||||||||||||||||||
impairment losses | |||||||||||||||||||||||||||||||||||||||||||||
other items | |||||||||||||||||||||||||||||||||||||||||||||
increase in cash and cash equivalents, net of effects of acquisitions and divestitures, resulting from changes in: | |||||||||||||||||||||||||||||||||||||||||||||
income taxes payable | |||||||||||||||||||||||||||||||||||||||||||||
acquisitions of businesses, net of cash acquired of 9, 5 and 10 in fiscal 2013, 2012 and 2011, respectively | |||||||||||||||||||||||||||||||||||||||||||||
net proceeds (payments) for purchase price adjustments related to prior year acquisitions | |||||||||||||||||||||||||||||||||||||||||||||
issuance of long-term debt, net of offering costs | |||||||||||||||||||||||||||||||||||||||||||||
dividends payments | |||||||||||||||||||||||||||||||||||||||||||||
total cash flows from financing activities of continuing operations | |||||||||||||||||||||||||||||||||||||||||||||
effect of foreign currency exchange rate changes on cash and cash equivalents | |||||||||||||||||||||||||||||||||||||||||||||
cash flows from continuing operations: | |||||||||||||||||||||||||||||||||||||||||||||
increase in cash and cash equivalents, excluding effects of acquisitions and divestitures, resulting from changes in: | |||||||||||||||||||||||||||||||||||||||||||||
acquisitions of businesses, net of cash acquired of 5, 10 and 8 in fiscal 2012, 2011 and 2010, respectively | |||||||||||||||||||||||||||||||||||||||||||||
net payments for purchase price adjustments related to prior year acquisitions | |||||||||||||||||||||||||||||||||||||||||||||
total cash flows from continuing operations | |||||||||||||||||||||||||||||||||||||||||||||
acquisitions of businesses, net of cash acquired of 10, 8 and 5 in fiscal 2011, 2010 and 2009, respectively | |||||||||||||||||||||||||||||||||||||||||||||
total cash flows from operations | |||||||||||||||||||||||||||||||||||||||||||||
acquisitions of businesses, net of cash acquired of 8, 5 and 29 in fiscal 2010, 2009 and 2008, respectively | |||||||||||||||||||||||||||||||||||||||||||||
total cash flows used in investing activities | |||||||||||||||||||||||||||||||||||||||||||||
total cash flows used in financing activities | |||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of year—continuing operations | |||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of year—discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at end of year—continuing operations |
We provide you with 20 years of cash flow statements for Leidos stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Leidos stock. Explore the full financial landscape of Leidos stock with our expertly curated income statements.
The information provided in this report about Leidos stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.